The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Do pancreatic cancer (PDA) stem cell markers predict biologic behavior?
 
Ibrahim Halil Sahin
No Relationships to Disclose
 
Mesruh Turkekul
No Relationships to Disclose
 
Marinela Capanu
No Relationships to Disclose
 
Gokce Askan
No Relationships to Disclose
 
Breanna McMahon
No Relationships to Disclose
 
Kenneth H. Yu
No Relationships to Disclose
 
Maeve Aine Lowery
No Relationships to Disclose
 
Olca Basturk
No Relationships to Disclose
 
Christine Iacobuzio-Donahue
No Relationships to Disclose
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Aduro Biotech; Astellas Pharma (I); Celgene; Celsion (I); Cipla; Exelixis (I); Gilead Sciences; Hexal (I); IntegraGen (I); Jennerex (I); Lilly (I); MedImmune; Merrimack; Novartis (I); Pharmacyclics; Sanofi; Silenseed; Vicus Therapeutics
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Immunomedics (Inst); Incyte (Inst); Momenta Pharmaceuticals (Inst); Myriad Genetics (Inst); OncoMed (Inst); Polaris (Inst); Sanofi (Inst)